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Abstract 
The objective of this study was to determine if β-hydroxybutyrate (BHB) altered inflammatory responses 
in macrophages challenged with a common mastitis pathogen, Streptococcus uberis. Mouse 
macrophages (RAW 264.7 line) were cultured either in the presence or absence of BHB for 24 h, and then 
challenged or not with S. uberis. Relative transcript abundance of cell membrane receptors (TLR2 and 
GPR109a), cytokines (IL-1β, IL-10, TNFα, and TGFβ), and chemokines (CXCL2 and CCL5) were determined 
using quantitative real-time polymerase chain reaction (qPCR) and normalized against the geometric 
mean of HPRT and B2M. Streptococcus uberis activated the macrophages, noted by greater transcript 
abundance of analyzed genes. Intriguingly, S. uberis increased GPR109a mRNA abundance, a receptor 
that is activated by BHB. Consequently, BHB dose-dependently increased transcript abundance of the pro-
inflammatory cytokine (IL-1β) and the anti-inflammatory cytokine (IL-10) but had no effect on TNFα or 
TGFβ. Moreover, BHB increased mRNA abundance of the chemokines, CXCL2 and CCL5. These data 
suggest a dysregulated immune response toward S. uberis due to BHB treatment, similar to what is seen 
in transition dairy cows. Future studies should be conducted in vivo to test the effect of BHB on immune 
function during an intramammary challenge. 
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Summary
The objective of this study was to determine if β-hydroxybutyrate (BHB) altered 
inflammatory responses in macrophages challenged with a common mastitis pathogen, 
Streptococcus uberis. Mouse macrophages (RAW 264.7 line) were cultured either in the 
presence or absence of BHB for 24 h, and then challenged or not with S. uberis. Rela-
tive transcript abundance of cell membrane receptors (TLR2 and GPR109a), cytokines 
(IL-1β, IL-10, TNFα, and TGFβ), and chemokines (CXCL2 and CCL5) were deter-
mined using quantitative real-time polymerase chain reaction (qPCR) and normal-
ized against the geometric mean of HPRT and B2M. Streptococcus uberis activated the 
macrophages, noted by greater transcript abundance of analyzed genes. Intriguingly, 
S. uberis increased GPR109a mRNA abundance, a receptor that is activated by BHB. 
Consequently, BHB dose-dependently increased transcript abundance of the pro-
inflammatory cytokine (IL-1β) and the anti-inflammatory cytokine (IL-10) but had no 
effect on TNFα or TGFβ. Moreover, BHB increased mRNA abundance of the chemo-
kines, CXCL2 and CCL5. These data suggest a dysregulated immune response toward 
S. uberis due to BHB treatment, similar to what is seen in transition dairy cows. Future 
studies should be conducted in vivo to test the effect of BHB on immune function 
during an intramammary challenge.
Introduction
Mastitis is the most common and costly disease in the dairy industry, impairing animal 
welfare and decreasing milk production. The incidence of clinical mastitis is dramati-
cally greater during the first few weeks after calving than in the rest of the lactation. At 
the beginning of lactation, a depression of feed intake occurs simultaneously with an 
increase in energy demand, resulting in metabolic stress and negative energy balance. 
Consequently, dairy cattle mobilize fat reserves, liberating non-esterified fatty acids 
(NEFA). These fatty acids are transported to the liver for energy production. However, 
not all NEFA are completely oxidized, resulting in the production of β-hydroxybutyrate 
(BHB), a major ketone body. This ketone body has long been associated with disease 
in early lactation, but it is important to recognize that association does not discrimi-
nate between causative disease mediators and adaptive responses that help resolve the 
disease. The association between ketosis and mastitis is likely due to the decreased func-
tion of host innate immune cells exposed to BHB. When neutrophils were cultured 
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with BHB at various concentrations (0.1 to 8.0 mM), there was a stepwise reduction 
in extracellular killing of bacteria. Additionally, leukocytes from ketotic cows had a 
reduced ability to migrate toward an inflammatory response relative to those isolated 
from non-ketotic cows. 
Streptococcus uberis is a common environmental mastitis pathogen that is responsible for 
a large proportion of mastitis during the first month of lactation, when negative energy 
balance is exacerbated. Therefore, it seems likely that BHB may be impairing immune 
responses toward this pathogen in early lactation dairy cattle. Hence, the objective of 
this experiment was to examine the effect of BHB on inflammatory mediators from 
macrophages during a Streptococcus uberis challenge. We hypothesized that BHB would 
attenuate inflammatory responses in a dose-dependent manner. 
Experimental Procedures
Bacterial Strain and Conditions
Streptococcus uberis (kindly provided by Dr. Petersson-Wolfe, Department of Dairy 
Science, Virginia Tech) was originally isolated from a dairy cow with mastitis and stored 
in 10% skim milk at -80°C. Bacteria were streaked on an esculin blood agar plate and 
incubated for 24 hours. Five colonies were then cultured in Todd-Hewitt broth and 
incubated for 7 hours at 37°C on an orbital shaker. Bacterial suspension was pelleted 
with centrifugation, washed with sterile phosphate-buffered saline, and resuspended in 
Dulbecco’s Modified Eagle Medium (DMEM) containing 1% L-glutamine and 10% 
heat-inactivated fetal bovine serum. Serial dilutions were used to achieve the desired 
concentration of colony-forming units for challenge, and challenge inoculum concen-
tration was verified using drop plating onto esculin blood agar. 
Cell Culture Conditions and Treatments
Mouse macrophages (RAW 264.7 line) were cultured in DMEM supplemented 
with 1% L-glutamine, 10% heat-inactivated fetal bovine serum, and 0.2% penicillin-
streptomycin. Twenty-four-well plates (n = 8 wells per treatment group) were seeded 
with 1 × 105 cells and incubated for 24 hours at 37°C and 5% CO2.
 Cells were then 
either treated with β-hydroxybutyrate (Sigma Aldrich) at various concentrations 
(0 mM, 0.6 mM, 1.2 mM, or 1.8 mM) or not for 24 hours to mimic ketosis. To main-
tain a neutral pH in culture media, β-hydroxybutyrate was added as sodium salt, and a 
treatment group with 1.8 mM added NaCl was included as an osmotic control. After 
the 24-hour incubation step, the medium was removed and fresh medium without anti-
biotics containing BHB at various concentrations (or not) and with or without 5 × 105 
CFU/mL of S. uberis were added for 6 hours. Cells were then lysed and stored at -80°C. 
RNA Isolation and qPCR
Total RNA was isolated from cell lysates using the RNeasy kit (Qiagen) and was quan-
tified using spectroscopy (NanoDrop Technologies Inc., Wilmington, DE). One micro-
gram of total RNA was used as template for the reverse transcriptase reaction using 
random primers. Quantitative real-time PCR was performed in duplicate with 200 nM 
gene-specific forward and reverse primers with real-time SYBR green fluorescent detec-
tion (7500 Fast Real-Time PCR System, Applied Biosystems). Primers were designed 
from mouse GenBank sequences and were designed to amplify an intron-spanning 
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region of the gene. Relative mRNA abundance was quantified by the 2-ΔCt method with 
the geometric mean of HPRT and B2M used to normalize values.
Statistical Analyses
Statistical analyses were conducted in PROC GLIMMIX SAS v. 9.4 (SAS Inst., Cary, 
NC). Orthogonal contrasts were performed to test the effect of S. uberis, overall effect 
of BHB within S. uberis challenged treatment groups, as well as linear and quadratic 
contrasts to test BHB dose responses. To meet the assumption of normality (PROC 
UNIVARIATE), all response variables required natural logarithmic transformation; 
least square means and standard errors were back-transformed. An outlier was defined if 
the observation had a studentized residual greater than 3 in absolute value, and there-
fore was removed from the analysis. Significance was declared at P ≤ 0.05. 
Results and Discussion
Streptococcus uberis Effects
As expected, Streptococcus uberis induced the immune activation in macrophages. This 
was evident through increased mRNA abundance of a pathogen recognition receptor, 
toll-like receptor 2 (TLR2, P = 0.03), and thus downstream increases of both pro- 
and anti-inflammatory cytokine mRNA abundance. In particular, S. uberis increased 
mRNA abundance (all P < 0.01) of pro-inflammatory cytokines interleukin (IL)-1β 
and tumor necrosis factor α (TNFα), as well as anti-inflammatory cytokines IL-10 and 
transforming growth factor β (TGFβ). Moreover, S. uberis increased mRNA abundance 
of two chemokines (CXCL2 and CCL5), which are proteins used to attract immune 
cells into inflamed tissue. Lastly, S. uberis increased mRNA abundance of GPR109a 
(P < 0.01), a receptor for BHB that has known anti-inflammatory effects when acti-
vated. This is intriguing, as these data could imply that S. uberis promotes immunolog-
ical tolerance, thus impairing the immune system’s ability to kill this pathogen. Regard-
less, an increase in GPR109a should result in macrophages that are more responsive to 
BHB ligation. 
Beta-Hydroxybutyrate Effects
Beta-Hydroxybutyrate increased mRNA abundance of both pro- and anti-inflamma-
tory cytokines, although these data should be interpreted with caution. First, BHB 
dose-dependently increased mRNA abundance of the potent anti-inflammatory cyto-
kine IL-10 (overall BHB effect, P = 0.01; linear BHB effect, P < 0.01) when compared 
to S. uberis challenged cells. Yet, BHB also dose-dependently increased mRNA abun-
dance of the pro-inflammatory cytokine IL-1β (overall BHB effect, P < 0.01; linear 
BHB effect, P < 0.01). Interleukin-1β data should be interpreted cautiously; this 
cytokine is post-translationally regulated more so than other cytokines, so a future study 
must confirm if the active, secreted protein form of this cytokine was also increased 
by BHB. An increase in both IL-1β and IL-10 is likely due to increased abundance 
of the receptor that controls their expression, TLR2 (overall BHB effect, P < 0.01; 
linear BHB effect, P = 0.01). Lastly, BHB increased mRNA abundance of chemokines 
CXCL2 (overall BHB effect P = 0.01; linear BHB effect, P = 0.04) and CCL5 (overall 
BHB effect, P = 0.03; linear BHB effect, P = 0.07). Again, these data could imply a 
more robust immune response, as a greater abundance of chemokines should result 
in more immune cells migrating into inflamed tissue in vivo. However, in a similar 
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study, BHB also increased chemokine mRNA abundance, yet this did not result in an 
increase in immune cells migrating into tissue. Thus, an increase in chemokine mRNA 
abundance may simply be a compensatory response in attempt to overcome a reduction 
in their efficacy. Future studies should examine protein abundance of these cytokines 
to ensure the transcriptional effects from BHB treatment indeed alter cytokine and 
chemokine protein profiles. 
Conclusions
Streptococcus uberis is responsible for a large proportion of mastitis during the first 
month of lactation. In the present study, S. uberis increased GPR109a mRNA abun-
dance, a receptor that is ligated by BHB. This resulted in a dose-dependent increase 
in mRNA abundance of both pro- and anti-inflammatory cytokines, including IL-1β 
and IL-10. An increase in the abundance of these cytokines could be indicative of the 
immune dysfunction that is typically seen in transition dairy cows. Future studies 
should be conducted in vivo to test the effect of BHB on immune function during an 
intramammary challenge. 
Figure 1. Effect of S. uberis and BHB on receptor (TLR2, A; GPR109a, B) transcript 
abundance in RAW 264.7 mouse macrophages. Streptococcus uberis challenge increased 
mRNA of the receptor for identification of Gram-positive pathogens, TLR2 (P = 0.03), as 
well as mRNA abundance of the receptor for BHB, GPR109a (P < 0.01). Beta-Hydroxybu-
tyrate treatment linearly increased TLR2 mRNA abundance (P = 0.01) when compared to 
cells treated with just S. uberis. Treatment groups include: control (CON), OC (osmotic 
control), OC + S. uberis, 0.6 mM BHB + S. uberis, 1.2 mM BHB + S. uberis, and 1.8 mM 
BHB + S. uberis. 
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Figure 2. Effect of S. uberis and BHB on pro-inflammatory (IL-1β, A; TNFα, B) and anti-
inflammatory (IL-10, C; TGFβ, D) cytokine transcript abundance in RAW 264.7 mouse 
macrophages. Streptococcus uberis challenge activated the macrophages, increasing both 
pro- and anti-inflammatory cytokine mRNA abundance (all P < 0.01). Beta-Hydroxybu-
tyrate treatment linearly increased IL-1β (P < 0.01) and IL-10 (P < 0.01) mRNA abun-
dance when compared to cells treated with just S. uberis, however, no effect of BHB was 
found on either TNFα or TGFβ. Treatment groups include: control (CON), OC (osmotic 
control), OC + S. uberis, 0.6 mM BHB + S. uberis, 1.2 mM BHB + S. uberis, and 1.8 mM 
BHB + S. uberis. 
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
6
Dairy Research 2019
Figure 3. Effect of S. uberis and BHB on chemokine (CXCL2, A; CCL5, B) transcript 
abundance in RAW 264.7 mouse macrophages. Streptococcus uberis challenge activated 
the macrophages, increasing both CXCL2 and CCL5 mRNA abundance (both P < 0.01). 
Beta-Hydroxybutyrate treatment linearly increased CXCL2 (P = 0.04) as well as increased 
CCL5 (P = 0.03) mRNA abundance when compared to cells treated with just S. uberis. 
Treatment groups include: control (CON), OC (osmotic control), OC + S. uberis, 
0.6 mM BHB + S. uberis, 1.2 mM BHB + S. uberis, and 1.8 mM BHB + S. uberis. 
